Insiders · Profile

Luly Jay R.

President and CEO at ENANTA PHARMACEUTICALS. Filing since 2 Jan 2014. CIK 0001571211

Company
Date
Role
Action
Shares
Amount
Of holding
5 Dec 2025
President and CEO
Sold at will
4,743
$67.49K
0.5%
12 Feb 2025
President and CEO
Bought
45,000
$256.05K
5.6%
6 Dec 2024
President and CEO
Sold on a plan
5,142
$41.44K
0.6%
5 Dec 2023
President and CEO
Sold at will
7,230
$69.62K
0.9%
13 Mar 2023
President and CEO
Sold, plan not stated
27,912
$1.26M
3.3%
16 Dec 2022
President and CEO
Sold, plan not stated
30,000
$1.34M
3.7%
15 Sep 2021
President and CEO
Sold, plan not stated
4,516
$266.70K
0.7%
6 Jul 2018
President and CEO
Sold, plan not stated
32,023
$4.01M
5.1%
5 Jul 2018
President and CEO
Sold, plan not stated
2,977
$368.57K
0.5%
17 May 2018
President and CEO
Sold, plan not stated
10,968
$1.16M
1.7%
16 May 2018
President and CEO
Sold, plan not stated
14,032
$1.48M
2.1%
9 Mar 2015
President and CEO
Sold, plan not stated
15,000
$500.52K
3.1%
20 Feb 2015
President and CEO
Sold, plan not stated
15,000
$530.29K
3.0%
5 Jan 2015
President and CEO
Sold, plan not stated
15,000
$756.46K
2.9%
1 Dec 2014
President and CEO
Sold, plan not stated
15,000
$680.82K
2.8%
3 Nov 2014
President and CEO
Sold, plan not stated
15,000
$637.81K
2.8%
1 Apr 2014
President and CEO
Sold, plan not stated
15,000
$587.54K
2.7%
10 Mar 2014
President and CEO
Sold, plan not stated
10,000
$384.87K
1.8%
14 Feb 2014
President and CEO
Sold, plan not stated
5,800
$220.97K
1.0%
2 Jan 2014
President and CEO
Sold, plan not stated
5,800
$162.70K
1.8%
20 decisions on file.